The pathogenesis of acromegaly. Clinical and immunocytochemical analysis in 75 patients.

E. Laws,B. Scheithauer,S. Carpenter,R. Randall,C. Abboud
DOI: https://doi.org/10.3171/JNS.1985.63.1.0035
IF: 5.408
1985-07-01
Journal of Neurosurgery
Abstract:A series of 75 patients with acromegaly and immunocytochemically characterized pituitary adenomas has been analyzed. Tumors secreting growth hormone (GH) only were found in 21% of cases. The remainder had tumors immunoreactive for more than one pituitary hormone: GH and prolactin in 31%; GH, prolactin, and glycoprotein in 40%; and GH and glycoprotein in 8%. Microadenomas were surgically treated in 17 patients with a success rate of 82%. Overall, normalization of basal GH secretion (to less than or equal to 5 ng/ml) was achieved in 54% of cases. The implications of these findings for the pathogenesis and neurosurgical management of acromegaly are discussed.
What problem does this paper attempt to address?